Utrophin is expressed in muscle in the foetus and at high levels in other tissues such as liver, lung and kidney throughout life in DMD patients (as well as healthy people) [9], [10], so increasing its production therapeutically in muscle would not risk inciting an immune response. Here, UTRN is linked to Duchenne muscular dystrophy.